Orange Book product · Generic (ANDA)
CALCIUM GLUCONATE IN SODIUM CHLORIDE
CALCIUM GLUCONATE
At a glance
Dec 30, 2025
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 30, 2025
6 mo ago
Today
Pharmaceutical detail
Active ingredient
CALCIUM GLUCONATE
Strength
1GM/50ML (20MG/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
AP
Application
ANDA 219619
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CALCIUM GLUCONATE
- 2025CALCIUM GLUCONATEBrand (NDA)
NDA 210906 · HQ SPCLT PHARMA
- 2017CALCIUM GLUCONATEBrand (NDA)
NDA 208418 · FRESENIUS KABI USA
- 2026CALCIUM GLUCONATEGeneric (ANDA)
ANDA 218840 · CAPLIN
- 2024CALCIUM GLUCONATEGeneric (ANDA)
ANDA 216611 · AMNEAL
- 2023CALCIUM GLUCONATEGeneric (ANDA)
ANDA 217689 · SOMERSET
- 2023CALCIUM GLUCONATE IN SODIUM CHLORIDEGeneric (ANDA)
ANDA 217174 · AMNEAL
- 2023CALCIUM GLUCONATEGeneric (ANDA)
ANDA 216541 · B BRAUN MEDICAL
- 2022CALCIUM GLUCONATEGeneric (ANDA)
ANDA 213071 · NIVAGEN PHARMS INC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
